Author:
Gouda M.A.,Hu M.I.,Cabanillas M.E.,Wu J.,Meric-Bernstam F.,Subbiah V.
Funder
Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
National Institutes of Health
Cancer Prevention and Research Institute of Texas
National Center for Advancing Translational Sciences
University of Texas MD Anderson Cancer Center
Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston
Reference9 articles.
1. Precision therapy for RET-altered cancers with RET inhibitors;Thein;Trends Cancer,2021
2. Targeting both sides of the GDF15-GFRAL-RET receptor complex: a new approach to achieve body weight homeostasis;Li;Genes Dis,2017
3. Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist;Benichou;Cell Metab,2023
4. Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice;Suriben;Nat Med,2020
5. The MIC-1/GDF15-GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases;Tsai;Cell Metab,2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献